QMS EVEROLIMUS ASSAY 0380000

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a user facility report with the FDA on 2017-09-14 for QMS EVEROLIMUS ASSAY 0380000 manufactured by Microgenics Corporation.

Event Text Entries

[86251269] Description of problem: on 21july2017 the following information was communicated to beckman coulter: customer reports erroneously low everolimus (ever) for one (1) patient generated by the au680 analyzer. The erroneous result was reported out of the laboratory. Sample was repeated on the same analyzer with resulting in same result. There was change/adjustment to patient treatment associated with this event. Investigation and analysis: customer reports calibration and quality controls meeting specifications on the day of incident. No data was provided. Customer reports the initial result <2 ng/ml, patient was redrawn to confirming result to <2 ng/ml. The erroneous low result was reported out of laboratory. Physician increased patient dosage of everolimus, causing patient to become toxic. Sample was repeated by reference laboratory resulting in normal levels. No data was provided. Patient had dialysis to bring toxic levels down. This did not result in death. No other details were provided. Applications specialist reviewed customer parameters, finding multiple assays to be incorrectly entered from a source not provided by microgenics. Assays included cyclosporine (csal/csah), tacrolimus (tac) and everolimus (evr). Applications specialist walked customer through proper parameter setting and validated system operation without further issue. No evidence of system or reagent malfunction. A follow-up with applications specialist confirms parameters were correct during and after installations stages, providing printouts. Review of oracle business intelligence (obi) database on 15 aug 2017, finds analyzer installed on 16 feb 2017. No reoccurrence of this issue has been reported. The available information suggests the failure mode is use error. Applications specialist found incorrect parameter setting for multiple assays. Cause of the event and conclusion: the failure mode of this event is use error. Applications specialist found incorrect parameter setting for multiple assays. No evidence of reagent or system malfunction.
Patient Sequence No: 1, Text Type: N, H10


[86251270] Erroneous low everolimus results with injury to patient. The customer stated that the instrument keeps auto diluting the test when it has not been programed to do so. According to the customer, the reagent volume is set to zero. On investigation, the apps manager found that erroneous low everolimus were generated due to this issue. The result was <2. The patient was redrawn to confirm the result. The results matched, but both were incorrect. The erroneous low result was reported out of the laboratory and the physician increased dosage of everolimus. The patient became toxic, a sample was run at a reference laboratory, and ultimately the patient had to have dialysis to bring the level down. This did not result in death.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3010939897-2017-00002
MDR Report Key6866863
Report SourceUSER FACILITY
Date Received2017-09-14
Date of Report2017-09-13
Date of Event2017-07-07
Date Mfgr Received2017-08-15
Date Added to Maude2017-09-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDAVE SCHULTENOVER
Manufacturer Street46500 KATO ROAD
Manufacturer CityFREMONT CA 94538
Manufacturer CountryUS
Manufacturer Postal94538
Manufacturer Phone5109795000
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameQMS EVEROLIMUS ASSAY
Generic NameEVEROLIMUS IMMUNOASSAY
Product CodeOUF
Date Received2017-09-14
Model Number0380000
Catalog Number0380000
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerMICROGENICS CORPORATION
Manufacturer Address46500 KATO ROAD FREMONT CA 94538 US 94538


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2017-09-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.